Regulation of CD8+ T cell exhaustion by let-7/Lin28b in different stages of life
Regulation of CD8+ T cell exhaustion by let-7/Lin28b in different stages of life
批准号:
10389670
负责人:
Viviana Isabel Maymi
金额:
$4.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-12-01 至 2026-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract
Though CD8+ T cell-based immunotherapies have revolutionized treatment for hematologic cancers and
chronic viral infections, T cell exhaustion remains a barrier to fully realizing their therapeutic potential. T cell
exhaustion is the hierarchical loss of proliferation, cytokine production, and effector function of CD8+ T cells after
chronic antigen stimulation. Not every T cell becomes exhausted to the same degree or at the same rate, but
the factors governing heterogeneity in susceptibility to exhaustion are undefined. The Rudd lab was the first to
show that a previously-overlooked source of heterogeneity within the naïve CD8+ T cell pool—developmental
origin—is deterministic in a CD8+ T cell’s fate after acute infection. We believe that developmental origin is also
consequential in chronic infection, for our preliminary data shows that neonatal CD8+ T cells (derived from the
fetal liver) are resistant to phenotypic and functional exhaustion, whereas adult cells (derived from adult bone
marrow) are more susceptible. We also showed that overexpressing Lin28b, an oncofetal RNA-binding protein
that negatively regulates let-7 microRNAs and is only expressed in fetal liver HSCs, is sufficient to convert the
adult phenotype to the neonatal one. Our objective is therefore to dissect the developmentally-regulated
programs underlying differential responses to chronic stimulation. We will use innovative approaches to test our
hypothesis that adult CD8+ T cells are more susceptible to exhaustion than neonatal cells due to age-related
differences in let-7/Lin28b expression that program metabolism away from aerobic glycolysis. In Aim 1, we will
determine how developmental origin and Lin28b expression impact propensity for CD8+ T cell exhaustion.
Results from this aim will make clear how distinct subsets of exhausted cells arise among differently-aged CD8+
T cells, and shed light on whether developmental pathways protect against irreversible exhaustion. In Aim 2, we
will determine how Lin28b-mediated metabolic programs underlie differently-aged cells’ susceptibility to become
exhausted. These results will provide a mechanistic explanation for how developmental imprinting affects T cell
exhaustion dynamics. By investigating the developmentally-distinct CD8+ T cell response to chronic infection,
and the role that let-7, Lin28b, and metabolic programing play in said response, this proposal will uncover a
previously-unexplored factor in determining T cell exhaustion. Because developmentally-ingrained pathways are
common to all T cells, understanding these pathways—and finding strategies to fine-tune them—will have wide-
reaching implications for neonatal disease, chronic infection, and cancer alike.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of CD8+ T cell exhaustion by let-7/Lin28b in different stages of life
-
批准号:10594406
-
项目类别:
-
资助金额:$4.34万
-
财政年份:2021
-
负责人:Viviana Isabel Maymi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖脂代谢重塑型金属多酚纳米药物促进CD8+ T细胞活化浸润增效PD-1抗体治疗三阴性乳腺癌的研究
-
批准号:2026JJ50635
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘芙蓉
-
依托单位:
前列腺癌CD8+ T细胞雄激素受体表达介导内分泌治疗耐药的机制研究
-
批准号:JCZRLH202601667
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Leptin通过调控MxA表达促进CD8+ T细胞活化参与白癜风发生发展的作用机制研究
-
批准号:2026JJ81680
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张慧明
-
依托单位:
CD8+ T细胞衰老的代谢调控研究
-
批准号:JCZRQNA202600019
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
核B7-H3调控DKK4介导的CD8+ T细胞耗竭影响结直肠癌远处转移的机制研究
-
批准号:JCZRQNB202600082
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
“增强型”铜死亡纳米药物改善CD8+ T细胞耗竭用于腺导管腺癌免疫治疗的研究
-
批准号:JCZRLH202600099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肠道菌群来源的色氨酸代谢物通过芳香烃受体(AhR)调控NMO中枢CD8+ T细胞浸润的机制研究
-
批准号:2026JJ80630
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周娟
-
依托单位:
长链非编码RNA Malat1通过PTEN/TCF-1促进记忆CD8+ T细胞分化的机
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李保华
-
依托单位:
细胞凋亡抑制蛋白2通过激活PPAR通路促进黑色素瘤中CD8+ T细胞脂肪酸代谢及抗肿瘤效应的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:孙嘉政
-
依托单位:
MHC-E限制性CD8+调节性T细胞抑制抗肿
瘤免疫反应的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:王蕾
-
依托单位: